Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
BAF312 is currently in clinical trials to treat multiple sclerosis
InChi: InChI=1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11
InChi: InChI=1S/C31H42N4O6S/c1-19(34(5)30(40)41-31(2
20(3):e138
Chemical Name: 6-O-alpha-D-Glucopyranosyl-D-glucitol mixed with 1-O-alpha-D-glucopyranosyl-D-mannitol
Perifosine Size:2mg solid BAF312 is currently in clinicalPerifosine is an orally active alkyl phosphocholine compound with potential antineoplastic activity. Targeting cellular membranes, perifosine modulates membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth. This agent also inhibits the anti apoptotic mitogen activated protein kinase (MAPK) pathway and modulates the balance between
US$ 173.00
US$ 182.00
US$ 341.50
US$ 196.90
US$ 529.00